Skip to main content
Equibles

Hans-Juergen Woerle, M.D.

Board Member

Seres Therapeutics, Inc. (MCRB)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Hans-Juergen Woerle, M.D.

Hans-Juergen Woerle, M.D. is recorded as Board Member at Seres Therapeutics, Inc. (MCRB). Seres Therapeutics, Inc. reported in an 8-K filed June 1, 2026 that Hans-Juergen Woerle, M.D. resigned as member of the board of directors, effective May 31, 2026. Seres Therapeutics, Inc. reported in an 8-K filed February 6, 2025 that Hans-Juergen Woerle, M.D. was appointed Class III director, effective February 4, 2025.

“On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.”
Seres Therapeutics, Inc. Form 8-K, filed June 1, 2026 · Read the filing
“On February 4, 2025, the Board of Directors (the "Board") of Seres Therapeutics, Inc. (the "Company") increased its size to provide for a total of nine directors authorized to serve on the Board and appointed Hans-Juergen Woerle, M.D., as a Class III director of the Company, effective immediately.”
Seres Therapeutics, Inc. Form 8-K, filed February 6, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Seres Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.